Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse Model

Antioxidants and Redox Signaling - United States
doi 10.1089/ars.2012.4946
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2016English

SGLT2 Inhibitor Ipragliflozin Alone and Combined With Pioglitazone Prevents Progression of Nonalcoholic Steatohepatitis in a Type 2 Diabetes Rodent Model

Physiological Reports
Physiology
2019English

Antifibrotic Effect of Pirfenidone in a Mouse Model of Human Nonalcoholic Steatohepatitis

Scientific Reports
Multidisciplinary
2017English

Comprehensive Circular RNA Expression Profiles in a Mouse Model of Nonalcoholic Steatohepatitis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Renoprotective Effects of a Novel Nox1/4 Inhibitor in a Mouse Model of Type 2 Diabetes

Clinical Science
Medicine
2012English

Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis

Hepatology
MedicineHepatology
2017English

Active Vitamin D3, 1,25-(Oh)2d3, Protects Against Macrovasculopathy in a Rat Model of Type 2 Diabetes Mellitus

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

P38 Mediates Mechanical Allodynia in a Mouse Model of Type 2 Diabetes

Molecular Pain
Molecular MedicineAnesthesiologyPain MedicineCellularMolecular Neuroscience
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy